Vialwirebiotech, curated
October 2, 2026, 11:45 AM
June 2, 2026
- 11:17 AM · Pharmaceutical Technology11:17 AMASCO 2026: Kelonia presents positive in vivo CAR-T data in multiple myeloma — Pharmaceutical Technology
- 10:28 AM · Pharmaceutical Technology10:28 AMASCO 2026: Mixed SCLC result for Legend’s LB2102, Novartis expedites manufacture — Pharmaceutical Technology
- 10:17 AM · Pharmaceutical Technology10:17 AMASCO 2026: Talzenna and Xtandi combo has first-line promise in HRR altered-mCSPC — Pharmaceutical Technology
- 10:03 AM · Pharmaceutical Executive10:03 AM<![CDATA[FDA Sends CRL to Cingulate for CTx-1301]]> — Pharmaceutical Executive
- 9:00 AM · BioWorld9:00 AMCEPI backs vaccine candidates for Bundibugyo Ebola virus — BioWorld
- 9:00 AM · BioWorld9:00 AMVoyager’s tau-targeted gene therapy VY-1706 gains IND approval — BioWorld
- 9:00 AM · BioWorld9:00 AMFDA approves IND for Iovance’s TIL therapy IOV-5001 — BioWorld
- 9:00 AM · BioWorld9:00 AMMJFF grants supports Lysoway’s TMEM175 agonist program — BioWorld
- 9:00 AM · BioWorld9:00 AMSeries A financing at Waypoint Bio supports CAR T programs — BioWorld
- 6:14 AM · Pharmaceutical Technology6:14 AMBMS secures FDA acceptance for Camzyos sNDA — Pharmaceutical Technology
- 6:00 AM · Drug Discovery World6:00 AMImmunic appoints Erik Lundgren as CEO — Drug Discovery World
June 1, 2026
- 9:08 PM · Pharmaceutical Technology9:08 PMATS 2026: Insmed shines in bronchiectasis with spotlight on Brinsupri — Pharmaceutical Technology
- 6:00 PM · STAT News
- 5:31 PM · STAT News
- 3:03 PM · BioPharma Dive3:03 PMRallyBio tries again for reverse merger, this time with Avenzo — BioPharma Dive
- 12:00 PM · BioWorld12:00 PMEdgewise sells muscular dystrophy assets to Servier for $2.65B — BioWorld
- 12:00 PM · BioWorld12:00 PMA revolution in pancreatic cancer — BioWorld
- 12:00 PM · BioWorld12:00 PMOculis shifts focus after phase III DME disappointment — BioWorld
- 12:00 PM · BioWorld12:00 PMPhase II bid Turns out safe, EASI, effective; AD topical island? — BioWorld
- 11:41 AM · Pharmaceutical Technology11:41 AMASCO26: Platinum-resistant ADC leader Elahere stumbles in platinum-sensitive disease — Pharmaceutical Technology
- 9:06 AM · PharmaVoice9:06 AMAstraZeneca aims for a new blockbuster run in cardio disease — PharmaVoice
- 9:00 AM · BioWorld9:00 AMPLT-012 shows efficacy across different MASH models — BioWorld
- 9:00 AM · BioWorld9:00 AMHIV integrase inhibitors divulged in MSD patent — BioWorld
- 9:00 AM · BioWorld9:00 AMXtalpi reports milestones under Dovetree collaboration — BioWorld
- 9:00 AM · BioWorld9:00 AMAlaw nominates CDK4 inhibitor AL-433 as development candidate — BioWorld
- 9:00 AM · BioWorld9:00 AMAleksia Therapeutics patents new CDK2 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMCEPI supports Moderna’s vaccine against Bundibugyo Ebola virus — BioWorld
- 9:00 AM · BioWorld9:00 AMDeep Apple Therapeutics synthesizes GIPR antagonists — BioWorld
- 9:00 AM · BioWorld9:00 AMLaverock Therapeutics awarded innovation grants — BioWorld
- 9:00 AM · BioWorld9:00 AMMuna Therapeutics discloses TREM2 agonists — BioWorld
- 7:00 AM · Drug Discovery World7:00 AMNICE recommends mepolizumab as COPD add-on treatment — Drug Discovery World
- 6:00 AM · Drug Discovery World6:00 AMCountable Labs raises $26m to commercialise PCR technology — Drug Discovery World
- 4:30 AM · STAT News4:30 AMSTAT+: Medicare still won’t say how much covering obesity drugs will cost — STAT News
- 4:00 AM · Drug Discovery World4:00 AMFirst patient dosed in glioblastoma gene therapy trial — Drug Discovery World
- 3:36 AM · Pharmaceutical Technology3:36 AMFDA approves AstraZeneca’s Imfinzi-BCG combination for NMIBC therapy — Pharmaceutical Technology